Analyst Ratings for Diebold Nixdorf Inc. (DBD)Updated: 2017-07-27
Shares of Diebold Nixdorf Inc. (NYSE:DBD) have received a consensus rating of Overweight from Wall Street analysts. About 30 days ago, DBD was issued an average rating of Overweight.
Of the 9 analysts covering the stock, 6 gave it a buy rating, 0 gave an overweight rating, 3 issued a hold rating, 0 gave an underweight rating, and 0 gave a sell rating. Compared to three months ago, there has been an increase of 0 in the number of analysts with a positive outlook on the stock. During this time, the number of analysts bearish on the stock has increased by 0.
A number of analysts gave price targets for DBD. The most optimistic analyst gave a price target of 32, implying potential capital gains of 38.83 percent. The most pessimistic price target was 26, which equates to a potential downside of 12.8 percent. It is advisable to not rely only on price targets or ratings, as these can be biased for some stocks.
Analysts have revised their earnings estimates downwards for this quarter, by about -75 percent on average, compared to last month. The average change in earnings estimates over the last 90 days is -75 percent. Meanwhile, fiscal year estimates have been revised downwards by -37.68 percent, compared to last month. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -37.87 percent.
Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, while 3 analysts revised their estimates downwards. During this time, 0 analysts made positive revisions in their estimates for this fiscal year's earnings, while 3 analysts decreased their estimates.
DBD has traded between a high of 31.85 and a low of 19.95 over the past year. Today's price is 15.54 percent above the 52-week low, and 27.63 percent below the high. DBD has a P/E ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The DBD value stock report compares DBD to some of its peers using value stock charts. The stock has a market capitalization of $1.72 billion. DBD is estimated to release their earnings results for the quarter on 0000-00-00, days from today.